PTAB pilot offers better chance to protect patents during inter partes review

The USPTO launched a pilot program that gives patent owners additional opportunities to amend the scope of patent claims during inter partes review proceedings. The pilot amendment process affords the biopharma industry more flexibility in protecting their patent claims from

Read the full 409 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE